Imeik Technology Reports 2025 Net Profit of 1.29 Billion Yuan

Stock News03-19

Imeik Technology Development Co.,Ltd. (300896.SZ) has released its annual report for 2025. The company's operating revenue reached 2.45 billion yuan, representing a decrease of 18.94% compared to the previous year. Net profit attributable to shareholders of the listed company was 1.29 billion yuan. After deducting non-recurring gains and losses, the net profit attributable to shareholders was 1.10 billion yuan. Basic earnings per share stood at 4.28 yuan. Additionally, the company proposed a cash dividend distribution of 8 yuan per 10 shares (before tax) to all shareholders. During the reporting period, the company's controlling subsidiary, Imeik International, completed a cash acquisition of an 85% equity stake in South Korea's REGEN Company for $190 million. REGEN operates production and R&D bases in Daejeon and Wonju, South Korea, and primarily manufactures the AestheFill and PowerFill products. These products have currently obtained regulatory approvals in 37 and 24 countries and regions respectively, establishing a significant presence in the international medical aesthetics market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107982309?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-19 21:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107982309","market":"us","top_or_hot":-1,"title":"Imeik Technology Reports 2025 Net Profit of 1.29 Billion Yuan","media":"Stock News","content":"<p>Imeik Technology Development Co.,Ltd. (300896.SZ) has released its annual report for 2025. The company's operating revenue reached 2.45 billion yuan, representing a decrease of 18.94% compared to the previous year. Net profit attributable to shareholders of the listed company was 1.29 billion yuan. After deducting non-recurring gains and losses, the net profit attributable to shareholders was 1.10 billion yuan. Basic earnings per share stood at 4.28 yuan. Additionally, the company proposed a cash dividend distribution of 8 yuan per 10 shares (before tax) to all shareholders. During the reporting period, the company's controlling subsidiary, Imeik International, completed a cash acquisition of an 85% equity stake in South Korea's REGEN Company for $190 million. REGEN operates production and R&D bases in Daejeon and Wonju, South Korea, and primarily manufactures the AestheFill and PowerFill products. These products have currently obtained regulatory approvals in 37 and 24 countries and regions respectively, establishing a significant presence in the international medical aesthetics market.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Imeik Technology Reports 2025 Net Profit of 1.29 Billion Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nImeik Technology Reports 2025 Net Profit of 1.29 Billion Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-19 21:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Imeik Technology Development Co.,Ltd. (300896.SZ) has released its annual report for 2025. The company's operating revenue reached 2.45 billion yuan, representing a decrease of 18.94% compared to the previous year. Net profit attributable to shareholders of the listed company was 1.29 billion yuan. After deducting non-recurring gains and losses, the net profit attributable to shareholders was 1.10 billion yuan. Basic earnings per share stood at 4.28 yuan. Additionally, the company proposed a cash dividend distribution of 8 yuan per 10 shares (before tax) to all shareholders. During the reporting period, the company's controlling subsidiary, Imeik International, completed a cash acquisition of an 85% equity stake in South Korea's REGEN Company for $190 million. REGEN operates production and R&D bases in Daejeon and Wonju, South Korea, and primarily manufactures the AestheFill and PowerFill products. These products have currently obtained regulatory approvals in 37 and 24 countries and regions respectively, establishing a significant presence in the international medical aesthetics market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300896","symbol_name":"爱美客","start_time":0,"source_url":"","article_id":"1107982309","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107982309","pubTimestamp":1773926429,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Imeik Technology Development Co.,Ltd. (300896.SZ) has released its annual report for 2025. The company's operating revenue reached 2.45 billion yuan, representing a decrease of 18.94% compared to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300896":"爱美客","BK0251":"专用设备"},"translate_title":"伊美克科技报告2025年净利润12.9亿元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300896":1},"content_text":"Imeik Technology Development Co.,Ltd. (300896.SZ) has released its annual report for 2025. The company's operating revenue reached 2.45 billion yuan, representing a decrease of 18.94% compared to the previous year. Net profit attributable to shareholders of the listed company was 1.29 billion yuan. After deducting non-recurring gains and losses, the net profit attributable to shareholders was 1.10 billion yuan. Basic earnings per share stood at 4.28 yuan. Additionally, the company proposed a cash dividend distribution of 8 yuan per 10 shares (before tax) to all shareholders. During the reporting period, the company's controlling subsidiary, Imeik International, completed a cash acquisition of an 85% equity stake in South Korea's REGEN Company for $190 million. REGEN operates production and R&D bases in Daejeon and Wonju, South Korea, and primarily manufactures the AestheFill and PowerFill products. These products have currently obtained regulatory approvals in 37 and 24 countries and regions respectively, establishing a significant presence in the international medical aesthetics market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107982309","isCrawlerRequest":true}